BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 19555941)

  • 21. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
    Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm.
    Lee KH; Lee SJ; Lee JK; Ryu JK; Kim EY; Kim TH; Moon JH; Lee WJ; Cho YK; Kim JJ
    Pancreas; 2014 Nov; 43(8):1306-11. PubMed ID: 25036913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms.
    Smith LA; Mckay CJ
    Minerva Med; 2014 Oct; 105(5):413-21. PubMed ID: 25000220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
    Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases.
    Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z
    JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
    Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
    Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.
    Schellhaas B; Vitali F; Wildner D; Görtz RS; Pfeifer L; Konturek PC; Neurath MF; Strobel D
    Med Sci Monit; 2017 Mar; 23():1483-1492. PubMed ID: 28348359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.
    Wong J; Weber J; Centeno BA; Vignesh S; Harris CL; Klapman JB; Hodul P
    J Gastrointest Surg; 2013 Jan; 17(1):78-84; discussion p.84-5. PubMed ID: 22948841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopic ultrasonography coupled with fine needle aspiration biopsy of intraductal papillary-mucinous tumours of the pancreas. Tool or gadget? A report of three cases.
    Barabino M; Santambrogio R; Pisani A; Leone S; Carrara S; Opocher E
    Chir Ital; 2007; 59(4):489-94. PubMed ID: 17966769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.
    Choi MG; Kim SW; Han SS; Jang JY; Park YH
    Arch Surg; 2006 Jan; 141(1):51-6; discussion 56. PubMed ID: 16415411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A history of acute pancreatitis in intraductal papillary mucinous neoplasms of the pancreas is a potential predictive factor for malignant papillary subtype.
    Tsutsumi K; Ohtsuka T; Oda Y; Sadakari Y; Mori Y; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreatology; 2010; 10(6):707-12. PubMed ID: 21242711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
    Ohtsuka T; Ideno N; Aso T; Nagayoshi Y; Kono H; Mori Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):356-61. PubMed ID: 22878836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and outcomes of pancreatic cystic neoplasms in liver transplant recipients.
    Liu K; Joshi V; van Camp L; Yang QW; Baars JE; Strasser SI; McCaughan GW; Majumdar A; Saxena P; Kaffes AJ
    World J Gastroenterol; 2017 Dec; 23(48):8526-8532. PubMed ID: 29358860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
    Munigala S; Javia SB; Agarwal B
    Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes after preoperative endoscopic ultrasonography and biopsy in patients undergoing distal pancreatectomy.
    Beane JD; House MG; Coté GA; DeWitt JM; Al-Haddad M; LeBlanc JK; McHenry L; Sherman S; Schmidt CM; Zyromski NJ; Nakeeb A; Pitt HA; Lillemoe KD
    Surgery; 2011 Oct; 150(4):844-53. PubMed ID: 22000199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study.
    Kim TH; Song TJ; Hwang JH; Yoo KS; Lee WJ; Lee KH; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Kim EY; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Oh DW; Kim MH
    Pancreatology; 2015; 15(4):405-10. PubMed ID: 25998516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.